Ross Divers, Alex S Cohen, Brita Elvevåg, Chelsea Chandler, Raymond Scott Turner, Brigid Reynolds, Catherine Diaz-Asper
{"title":"Speech production as an artificial intelligence-based 'process' measure of cognition sensitive to mild cognitive impairment and Alzheimer's disease.","authors":"Ross Divers, Alex S Cohen, Brita Elvevåg, Chelsea Chandler, Raymond Scott Turner, Brigid Reynolds, Catherine Diaz-Asper","doi":"10.1080/13854046.2025.2519827","DOIUrl":null,"url":null,"abstract":"<p><p><b>Objective:</b> Process scores in neuropsychological tests add incremental validity for detecting non-normative cognitive aging trajectories. However, process scores are laborious and time-consuming to derive. Using AI-driven natural language processing, we investigated objective speech markers related to speech production as a potential process score for measuring cognition, identifying mild cognitive impairment (MCI) and major neurocognitive disorder due to Alzheimer's disease (AD). <b>Method:</b> Older adults (<i>n =</i> 71; cognitively healthy; <i>n</i> = 29; MCI, <i>n</i> = 26; mild AD, <i>n</i> = 16) completed a brief battery of cognitive testing over the telephone, including a cognitive screener and four verbal memory tests. Six speech production features were extracted from the audio recordings of the verbal memory tests. <b>Results:</b> Pause times showed the highest convergence with cognitive screening performance and were best for distinguishing between people with or without MCI and with or without AD. This effect varied as a function of cognitive task. Verbal and semantic recall tasks showed the strongest effects. An \"unstructured\" autobiographical recall task showed negligible effects. <b>Conclusions:</b> AI-derived pause features in speech during verbal memory tests can serve as a process score of cognitive functioning that captures neurodegeneration, though cognitive tasks must be considered. The present findings reflect an important step forward for developing speech analysis for objectively quantifying cognitive dysfunctions in people with neurodegenerative disorders.</p>","PeriodicalId":55250,"journal":{"name":"Clinical Neuropsychologist","volume":" ","pages":"1-16"},"PeriodicalIF":3.0000,"publicationDate":"2025-07-07","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Clinical Neuropsychologist","FirstCategoryId":"102","ListUrlMain":"https://doi.org/10.1080/13854046.2025.2519827","RegionNum":3,"RegionCategory":"心理学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q2","JCRName":"CLINICAL NEUROLOGY","Score":null,"Total":0}
引用次数: 0
Abstract
Objective: Process scores in neuropsychological tests add incremental validity for detecting non-normative cognitive aging trajectories. However, process scores are laborious and time-consuming to derive. Using AI-driven natural language processing, we investigated objective speech markers related to speech production as a potential process score for measuring cognition, identifying mild cognitive impairment (MCI) and major neurocognitive disorder due to Alzheimer's disease (AD). Method: Older adults (n = 71; cognitively healthy; n = 29; MCI, n = 26; mild AD, n = 16) completed a brief battery of cognitive testing over the telephone, including a cognitive screener and four verbal memory tests. Six speech production features were extracted from the audio recordings of the verbal memory tests. Results: Pause times showed the highest convergence with cognitive screening performance and were best for distinguishing between people with or without MCI and with or without AD. This effect varied as a function of cognitive task. Verbal and semantic recall tasks showed the strongest effects. An "unstructured" autobiographical recall task showed negligible effects. Conclusions: AI-derived pause features in speech during verbal memory tests can serve as a process score of cognitive functioning that captures neurodegeneration, though cognitive tasks must be considered. The present findings reflect an important step forward for developing speech analysis for objectively quantifying cognitive dysfunctions in people with neurodegenerative disorders.
期刊介绍:
The Clinical Neuropsychologist (TCN) serves as the premier forum for (1) state-of-the-art clinically-relevant scientific research, (2) in-depth professional discussions of matters germane to evidence-based practice, and (3) clinical case studies in neuropsychology. Of particular interest are papers that can make definitive statements about a given topic (thereby having implications for the standards of clinical practice) and those with the potential to expand today’s clinical frontiers. Research on all age groups, and on both clinical and normal populations, is considered.